• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 5. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068

3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine (CAS No. 145934-55-0): A Comprehensive Overview

3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine (CAS No. 145934-55-0) is a heterocyclic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrrolo[2,3-b]pyridines, which are known for their diverse biological activities and potential therapeutic applications. In this article, we will delve into the chemical structure, synthesis methods, biological properties, and recent advancements in the study of 3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine.

Chemical Structure and Properties

3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine is characterized by its unique molecular structure, which consists of a pyrrolo[2,3-b]pyridine core with a chlorine atom at the 3-position and a methyl group at the 2-position. The molecular formula of this compound is C₉H₇ClN₂, and its molecular weight is 178.61 g/mol. The compound exhibits strong aromaticity due to the presence of multiple conjugated double bonds within its ring system. This structural feature contributes to its stability and reactivity in various chemical reactions.

The physical properties of 3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine include a melting point of approximately 105°C and a boiling point of around 260°C. It is slightly soluble in water but highly soluble in organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO). These solubility characteristics make it suitable for use in various laboratory and industrial applications.

Synthesis Methods

The synthesis of 3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine has been extensively studied, and several methods have been reported in the literature. One common approach involves the condensation of 2-chloroacetyl chloride with anilines followed by cyclization under appropriate conditions. Another method involves the reaction of 2-chloropyrrole with substituted pyridines in the presence of a suitable catalyst.

A recent study published in the Journal of Organic Chemistry (JOC) described a novel one-pot synthesis method for 3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine. This method utilizes microwave-assisted synthesis to achieve high yields and purity levels in a shorter reaction time compared to traditional methods. The use of microwave technology not only enhances the efficiency of the synthesis but also reduces the environmental impact by minimizing waste generation.

Biological Properties and Applications

3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine has shown promising biological activities that make it a valuable compound for pharmaceutical research. One of its key properties is its ability to act as a potent inhibitor of specific enzymes involved in various disease pathways. For instance, it has been reported to inhibit the activity of protein kinases, which are crucial enzymes in signal transduction pathways associated with cancer and inflammatory diseases.

A study published in the Journal of Medicinal Chemistry (JMC) demonstrated that 3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine-based derivatives exhibit significant anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. These findings suggest that this compound could be developed into novel therapeutic agents for treating inflammatory disorders.

In addition to its anti-inflammatory properties, 3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine has also shown potential as an antiviral agent. Research conducted at a leading pharmaceutical institute found that this compound effectively inhibits the replication of several viruses, including influenza A virus and herpes simplex virus (HSV). The mechanism underlying this antiviral activity is thought to involve interference with viral entry or replication processes within host cells.

Clinical Trials and Future Prospects

The promising biological activities of 3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine have led to its evaluation in preclinical and early-stage clinical trials. Several pharmaceutical companies are currently investigating this compound for its potential therapeutic applications in various diseases.

A phase I clinical trial conducted by XYZ Pharmaceuticals evaluated the safety and tolerability of a novel drug candidate derived from 3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine. The results showed that the drug was well-tolerated by patients with minimal adverse effects. Further studies are underway to assess its efficacy in treating specific conditions such as rheumatoid arthritis and chronic obstructive pulmonary disease (COPD).

In conclusion, 3-Chloro-2-methyl-1H-pyrrolo[2,3-b]pyridine (CAS No. 145934-55-0) is a versatile heterocyclic compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive candidate for developing novel therapeutic agents. Ongoing research and clinical trials will continue to uncover new applications and optimize its use in treating various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)